AXSM News and Press, Axsome Therapeutics Inc. From 08/30/23

2023-08-30 08:00:00 ET Investing in stocks isn't just for the rich and famous since quality stocks can be found at almost any price. Some are trading for well above $1,000 per share, while others go for less than $100 apiece. However, finding stocks under $100 may be better for those who ar...

2023-08-22 18:05:22 ET More on Axsome Therapeutics Axsome Therapeutics: 'Buy' The Auvelity Launch (Rating Upgrade) Axsome: NDA Resubmission AXS-07 And Other Catalysts Make This A Must Watch BofA upgrades Axsome to neutral, cites improved outlook for MDD drug ...

2023-08-20 23:55:36 ET Summary The S&P 500 experienced a strong reversal to end the week, suggesting a buoyant start to the next week. The market is anticipating harsh rhetoric from Powell at Jackson Hole, with expectations of one more rate hike and no rate cuts until 2025. ...

2023-08-19 05:52:00 ET Don't let anyone tell you that you must have a boatload of money to get started investing in stocks. It's simply not true. Sure, you'll need some upfront cash. However, even a modest amount is enough to scoop up shares of some companies with exciting prospects. ...

2023-08-16 14:13:34 ET BofA Securities has upgraded Axsome Therapeutics ( NASDAQ: AXSM ) to neutral, citing an improved outlook for the company's drug Auvelity for major depressive disorder, or MDD. The investment bank said it was upgrading the stock primarily because Axsome's M...

2023-08-08 18:12:18 ET BofA Securities has upgraded Axsome Therapeutics ( NASDAQ: AXSM ) to neutral, citing an improved outlook for the company's drug Auvelity for major depressive disorder, or MDD. The investment bank said it was upgrading the stock primarily because Axsome's M...

2023-08-07 14:46:11 ET Axsome Therapeutics, Inc. (AXSM) Q2 2023 Earnings Conference Call August 07, 2023, 08:00 AM ET Company Participants Mark Jacobson - IR Herriot Tabuteau - CEO Nick Pizzie - CFO Lori Englebert - EVP, Commercial and Business Development ...

2023-08-07 12:00:27 ET Image source: The Motley Fool. Axsome Therapeutics (NASDAQ: AXSM) Q2 2023 Earnings Call Aug 07, 2023 , 8:00 a.m. ET Operator Continue reading For further details see: Axsome Therapeutics (AXSM) Q2 2023 Earnings Call...

2023-08-07 07:01:35 ET Axsome Therapeutics press release ( NASDAQ: AXSM ): Q2 GAAP EPS of -$1.54 misses by $0.30 . The net loss in the second quarter of 2023 reflects $23.6 million in non-cash charges, comprised of $15.9 million of non-cash stock-based compensation exp...

Total 2Q 2023 product revenue of $46.7 million Auvelity ® 2Q 2023 net product sales of $27.6 million, representing 76% quarter-over-quarter growth Sunosi ® 2Q 2023 net product revenue of $19.1 million Pro forma second quarter cash balanc...